Results 51 to 60 of about 33,349 (194)

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

The Laryngoscope, EarlyView.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best, Aaron D. Friedman, Clark A. Rosen, Robert T. Sataloff, Laura A. Matrka, H. Steven Sims, David E. Rosow, Nabil F. Saba, David G. Lott, Adam M. Klein, Ted Mau, Milan R. Amin, Kathryn A. Wikenheiser‐Brokamp, Scott M. Norberg, Kim McClellan, Geoffrey D. Young, Clint T. Allen, on behalf of the Recurrent Respiratory Papillomatosis Foundation   +17 more
wiley   +1 more source

Newer vaccines (measles-rubella, human papillomavirus, rotavirus, and pneumococcal conjugate vaccine) introduction: Experience from Northern India

International Journal of Noncommunicable Diseases, 2018
Vaccines are essential to ensure that the population is immune to certain diseases, and immunization is one of the most cost-effective interventions to prevent the occurrence of the diseases.
Madhu Gupta, Kanica Kaushal, Nikita Sharma, Atul Gupta, Abu Mohammad Bashar, Suresh Dalpath, Shivani Gupta, G B Singh   +7 more
doaj   +1 more source

Nucleic acid vaccines for human papillomavirus; prevention or treatment [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2019
Introduction: Cervical cancer is the fourth common cancer among women. In almost all cases of this cancer, infection to a high risk human papilloma virus (HPV) especially type 16 and 18 is observed.
Solmaz Moniri Javadhesari, Sepehr Pourseif, Keyvan Khakpour   +2 more
doaj   +1 more source

Infection risk in rheumatoid arthritis patients treated with biologic and targeted therapies

Rheumatology &Autoimmunity, EarlyView.
In this context, infections associated with each biologic and targeted drug are summarized to inform the stratification of RA patients, including the characteristics of the susceptible patients and their concomitant therapy. We aim to provide a benefit‐risk analysis for clinical decision, and vital indications for the prevention of highly correlated ...
Lujing Wang, Jieshi Lin, Jie Qian
wiley   +1 more source

Vaccines against papillomavirus infections and disease

Salud Pública de México, 2003
Squamous cell carcinoma of the uterine cervix is the second cause of cancer-related deaths in women, the higher incidence being observed in developing countries.
Villa Luisa Lina
doaj  

Prophylactic human papillomavirus vaccines [PDF]

Journal of Clinical Investigation, 2006
Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the second most common cause of death from cancer among women worldwide. This Review examines prophylactic HPV subunit vaccines based on the ability of the viral L1 capsid protein to form virus-like particles (VLPs) that induce high levels of neutralizing antibodies ...
Douglas R, Lowy, John T, Schiller
openaire   +2 more sources

Introducing self‐sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
In this pilot study, HPV self‐sampling reached a 1.9% uptake among screening non‐attenders. Participants found the method acceptable, although overall screening coverage did not increase during the first implementation year. Abstract Introduction HPV primary testing is the preferred method for cervical cancer screening worldwide and enables vaginal ...
Saara Kyllönen, Satu Saloranta, Saara Kares, Anu Mustila, Karolina Louvanto   +4 more
wiley   +1 more source

Difference in Knowledge About HPV, HPV Vaccination, and Influencing Factors Between Healthcare and Non-Healthcare Students of the University of Rijeka

Hygiene
Background: Human papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide and a major cause of several cancers. HPV vaccination is the most effective measure of preventing HPV infection, but knowledge and attitudes ...
Sandro Kresina, Nataša Ivančić Jokić, Vlatka Sotošek, Helena Glibotić Kresina, Danko Bakarčić, Sara Kresina, Tea Ivančić Jokić, Maja Šikić Pogačar, Karolina Vušković Ćosić, Neda Smiljan Severinski   +9 more
doaj   +1 more source

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination

npj Vaccines, 2023
Gardasil® (Merck) and Cervarix® (GlaxoSmithKline) both provide protection against infection with Human Papillomavirus 16 (HPV16) and Human Papillomavirus 18 (HPV18), that account for around 70% of cervical cancers. Both vaccines have been shown to induce
Vicky Roy, Wonyeong Jung, Caitlyn Linde, Emily Coates, Julie Ledgerwood, Pamela Costner, Galina Yamshchikov, Hendrik Streeck, Boris Juelg, Douglas A. Lauffenburger, Galit Alter   +10 more
doaj   +1 more source

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea, Dario Colacurci, Giorgia D'Apice, Laura Letizia Mazzarelli, Massimiliano Pellicano, Luigi Falco, Ginevra Sepe, Oriana Imperatore, Giuseppe Maria Maruotti, Maurizio Guida, Laura Sarno   +10 more
wiley   +1 more source